Filing Details
- Accession Number:
- 0001628280-21-004076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-05 17:02:30
- Reporting Period:
- 2021-03-03
- Accepted Time:
- 2021-03-05 17:02:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1793294 | Ppd Inc. | PPD | Services-Commercial Physical & Biological Research (8731) | 453806427 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1801744 | Glen Donovan | C/O Ppd, Inc. 929 North Front Street Wilmington NC 28401 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-03-03 | 16,347 | $10.59 | 19,347 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-03-03 | 16,347 | $35.62 | 3,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-03-03 | 16,347 | $0.00 | 16,347 | $10.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-07-24 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.59 to $35.70, inclusive. The reporting person undertakes to provide to PPD, Inc. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option vested based on the Issuer's satisfaction of certain EBITDA-based vesting conditions. Options listed in the table do not include an additional 7,974 stock options eligible to vest based on the Issuer's satisfaction of certain EBITDA-based vesting conditions for the fiscal year ending December 31, 2021.